欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4318/001
药品名称Abacavir/Lamivudine Sandoz 600 mg / 300 mg film-coated tablets
活性成分
    • Abacavir hydrochloride 600.0 mg
    • Lamivudine 300.0 mg
剂型Film-coated tablet
上市许可持有人Sandoz B.V. Veluwezoom 22 1327 AH Almere The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Abacavir/Lamivudine Sandoz 600 mg/300 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Abacavir/Lamivudin Sandoz 600 mg/300 mg - Filmtabletten
    • Sweden (SE)
    • Poland (PL)
      Abacavir + Lamivudine Sandoz
    • Estonia (EE)
      ABACAVIR/LAMIVUDINE SANDOZ
许可日期2016/04/19
最近更新日期2024/11/04
药物ATC编码
    • J05AR02 lamivudine and abacavir
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase